Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Nitrogen Heterocycles. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117586310A reveals a novel Ni-Al bimetallic catalyst for enantioselective C(sp3)-H activation, offering cost reduction in pharmaceutical intermediates manufacturing and high-purity chiral nitrogen-containing heterocycles.
Patent CN102153501A details a metal-free organocatalytic synthesis of chiral pyrrolidines and piperidines with high enantioselectivity, offering cost-effective routes for pharmaceutical intermediates.